Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tan

Showing results (31-40 of 640) with videos related to

Pageof 64
Sort By:
Clinical Breast Cancer|November 20, 2024
A Clinical Review of Subcutaneous Trastuzumab and the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast CancerJulia L Ziegengeist, Antoinette R Tan
Clean Technologies and Environmental Policy|June 26, 2023
Cost and water footprint trade-off in a supply chain optimization modelDennis E Cruz, Raymond R Tan
Expert Opinion on Biological Therapy|November 22, 2021
Combination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancerAshley Matusz-Fisher, Antoinette R Tan
Journal of Pathology Informatics|August 2, 2019
Computational Algorithms that Effectively Reduce Report Defects in Surgical PathologyJay J Ye, Michael R Tan
Seminars in Oncology|November 13, 2003
Ongoing adjuvant trials with trastuzumab in breast cancerAntoinette R Tan, Sandra M Swain
Contact Dermatitis|January 22, 2000
Allergic contact dermatitis from Primula auricula and Primula denticulataC Aplin, R Tan, C Lovell
Seminars in Oncology|August 11, 2001
Adjuvant chemotherapy for breast cancer: an updateA R Tan, S M Swain
Seminars in Oncology|November 14, 2001
Novel agents: clinical trial designA R Tan, S M Swain
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?Antoinette R Tan, Deborah L Toppmeyer
Journal of the American Academy of Dermatology|January 1, 1990
Effect of plasmapheresis therapy on circulating levels of pemphigus antibodiesR Tan-Lim, J C Bystryn
Pageof 64

Showing results (31-40 of 640) with videos related to

Sort By:
Pageof 64
Clinical Breast Cancer|November 20, 2024
A Clinical Review of Subcutaneous Trastuzumab and the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast CancerJulia L Ziegengeist, Antoinette R Tan
Clean Technologies and Environmental Policy|June 26, 2023
Cost and water footprint trade-off in a supply chain optimization modelDennis E Cruz, Raymond R Tan
Expert Opinion on Biological Therapy|November 22, 2021
Combination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancerAshley Matusz-Fisher, Antoinette R Tan
Journal of Pathology Informatics|August 2, 2019
Computational Algorithms that Effectively Reduce Report Defects in Surgical PathologyJay J Ye, Michael R Tan
Seminars in Oncology|November 13, 2003
Ongoing adjuvant trials with trastuzumab in breast cancerAntoinette R Tan, Sandra M Swain
Contact Dermatitis|January 22, 2000
Allergic contact dermatitis from Primula auricula and Primula denticulataC Aplin, R Tan, C Lovell
Seminars in Oncology|August 11, 2001
Adjuvant chemotherapy for breast cancer: an updateA R Tan, S M Swain
Seminars in Oncology|November 14, 2001
Novel agents: clinical trial designA R Tan, S M Swain
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?Antoinette R Tan, Deborah L Toppmeyer
Journal of the American Academy of Dermatology|January 1, 1990
Effect of plasmapheresis therapy on circulating levels of pemphigus antibodiesR Tan-Lim, J C Bystryn
Pageof 64